ArticleCancers2024

Comparing Lenvatinib/Pembrolizumab with Atezolizumab/Bevacizumab in Unresectable Hepatocellular Carcinoma: A Real-World Experience with Propensity Score Matching Analysis.

Yu-Chun Hsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.